Plain-English translation of NCT07587086 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This pilot study is testing whether two specialized imaging scans—one using a tracer called Fluorocholine and another using a tracer called Fluorodeoxyglucose—can help doctors better understand your specific type of breast cancer and predict how well you might respond to treatment. These scans are performed using a machine that combines PET and MRI technology to create detailed images of your breast and body.
Currently, doctors can identify breast cancer, but it's difficult to predict which patients will respond well to chemotherapy and which ones won't. This research aims to find imaging markers that could help personalize treatment decisions and improve outcomes for women with breast cancer.
You likely qualify if…
You likely don't qualify if…
You will receive two imaging scans on different days, at least 2 days apart. For each scan, you'll fast for 6 hours beforehand, then receive an injection of a radioactive tracer through an IV. You'll rest for about 45–60 minutes, then lie still in the scanner for 20–35 minutes while images are taken. A radiologist and nuclear medicine doctor will review your scans and share the results with your oncologist to help guide your treatment plan.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
Taiwan